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ABSTRACT
Objectives: To investigate the association between modiﬁable risk and protective factors and severe
cognitive impairment and dementia in the very old. Additionally, the present study tests the
predictive validity of the ‘LIfestyle for BRAin health’ (LIBRA) score, an index developed to assess an
individual’s dementia prevention potential.
Method: Two hundred seventy-eight individuals aged 85 years or older from the Cambridge City over-
75s cohort study were followed-up until death. Included risk and protective factors were: diabetes,
heart disease, hypertension, depression, smoking, low-to-moderate alcohol use, high cognitive
activity, and physical inactivity. Incident severe cognitive impairment was based on the Mini-Mental
State Examination (score: 0-17) and incident dementia was based on either post-mortem consensus
clinical diagnostic assessments or death certiﬁcate data. Logistic regressions were used to test
whether individual risk and protective factors and the LIBRA score were associated with severe
cognitive impairment or dementia after 18 years follow-up.
Results: None of the risk and protective factors or the LIBRA score was signiﬁcantly associated with
increased risk of severe cognitive impairment or dementia. Sensitivity analyses using a larger sample,
longer follow-up period, and stricter cut-offs for prevalent cognitive impairment showed similar
results.
Conclusion: Associations between well-known midlife risk and protective factors and risk for severe
cognitive impairment or dementia might not persist into very old age, in line with suggestions that
targeting these factors through lifestyle interventions should start earlier in life.
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Introduction
In 2012, dementia was proclaimed a public health priority by
the World Health Organization (World Health Organization and
Alzheimer’s Disease International, 2012). Given the current lack
of available treatments for dementia, research focus has shifted
to prevention strategies (Baumgart et al., 2015). Even if a future
cure for dementia becomes available, primary prevention
should arguably remain one of the pillars of public health cam-
paigns to reduce the number of affected individuals or to delay
symptom onset. Several studies suggest that targeting modiﬁ-
able risk factors is essential to reduce dementia risk (Barnes &
Yaffe, 2011; Deckers et al., 2015; Norton, Matthews, Barnes,
Yaffe, & Brayne, 2014). Questions still remain as to which factors
should be targeted and which period during a person’s lifespan
would be the window of opportunity for most effective and efﬁ-
cient prevention. Since only a few randomized controlled trials
have investigated the effects of single or multivariate risk factor
reduction on cognitive decline or dementia incidence (Ngandu
et al., 2016; van Charante et al., 2016), the evidence for most fac-
tors comes from observational studies (Barnes & Yaffe, 2011;
Deckers et al., 2015; Plassman, Williams, Burke, Holsinger, & Ben-
jamin, 2010). Recent systematic literature reviews and meta-
analyses showed consistent support for a wide range of modiﬁ-
able risk and protective factors associated with dementia,
including cardiovascular and metabolic factors (e.g.
hypertension, obesity, hypercholesterolemia, diabetes, coronary
heart disease), lifestyle factors (e.g. diet, smoking, physical activ-
ity, alcohol consumption, cognitive activity) and psycho-social
factors (e.g. depression) (Barnes & Yaffe, 2011; Baumgart et al.,
2015; Deckers et al., 2015; Norton et al., 2014; Plassman et al.,
2010). These factors could be targeted by tailored lifestyle inter-
ventions, preferably in midlife, when lifestyle adjustments are
more feasible and probably most effective by reducing brain
damage accumulated during long-term exposure to these fac-
tors (Lafortune et al., 2016). Indeed, previous studies have
shown that the effects of certain risk factors vary across the life
course. For instance, obesity and hypertension in midlife have
more pronounced effects on dementia risk rather than in late
life (Anstey, Cherbuin, Budge, & Young, 2011; Barnes & Yaffe,
2011; Deckers et al., 2015). Additionally, late life studies showed
inconsistent results regarding the predictive ability of health
and lifestyle factors (Anstey et al., 2011; Anstey, Lipnicki, & Low,
2008; Barnes & Yaffe, 2011; Power et al., 2011). There are a few
studies that looked at the effects of metabolic syndrome
(including obesity, hypertension, diabetes and hypercholesterol-
emia) towards cognitive decline. The association between meta-
bolic syndrome and cognitive decline, which is found to be
positive in younger populations, was not signiﬁcant in the very
old (Harrison et al., 2015; Katsumata et al., 2012). However, stud-
ies investigating the (combined) effects of modiﬁable risk and
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protective factors on dementia risk in a very old population (i.e.
85C years) are particularly rare.
Therefore, the overall aim of the current study is to inves-
tigate the association between known modiﬁable risk and
protective factors and severe cognitive impairment and
dementia in individuals aged 85 years and older, as part of
the Cambridge City over-75s cohort (CC75C) study, a longitu-
dinal study of ageing in the very old (Brayne, Huppert,
Paykel, & Gill, 1992; Fleming, Zhao, O’Connor, Pollitt, &
Brayne, 2007). In addition, the study tests the predictive
validity of the recently developed ‘LIfestyle for BRAin health’
(LIBRA) score (Deckers et al., 2015), a simple summary index
that assesses an individual’s dementia prevention potential
by combining information on major modiﬁable health and
lifestyle factors.
Methods
Study population
The CC75C study is a population-based study originally
started in 1985 to measure the prevalence of dementia in
people aged 75 years and over from a selection of geographi-
cally and socially representative general practices in the city
of Cambridge, United Kingdom (UK) (Brayne et al., 1992; Flem-
ing et al., 2007). From the original sample of 2610, a total of
2166 participants from all but one general practice formed
the sample that was followed-up every two to four years until
the last participant’s death after the ﬁnal survey in 2013
(year 28). Each survey used a structured interviewer-adminis-
tered schedule to collect information on socio-demographic
variables, activities of daily living, cognitive functioning
(Mini-Mental State Examination (MMSE) (Folstein, Folstein, &
McHugh, 1975), health problems, medication and use of
health and social services. After the ﬁrst survey, proxy infor-
mant interviews were sought as needed to minimize loss to
follow-up of the frailest individuals. From Survey 2 onwards,
participants were asked whether they were willing to partici-
pate in the brain donation program. Each study phase was
approved by the Cambridge Research Ethics Committee. At
Survey 4 (year 10), the most comprehensive assessment of
modiﬁable risk and protective factors took place and was
hence considered the baseline assessment for the present
study (nD 446; age rangeD 84–102), yielding a maximum fol-
low-up period of 18 years (see Figure 1).
Dementia and severe cognitive impairment diagnosis
Participants with dementia were identiﬁed using three CC75C
study data sources: (1) psychiatrist-administered assessments:
the Cambridge Diagnostic Examination for the Elderly
(CAMDEX) (Roth et al., 1986). In Survey 1, cognitively impaired
participants (MMSE scores 23) and one in three participants
with milder cognitive impairment (MMSE scores 24–25)
underwent CAMDEX assessments. CAMDEX assessments fol-
lowing Surveys 2 and 3 also included participants with high
cognitive scores (MMSE 26–30); (2) post-mortem consensus
clinical diagnostic assessments were conducted to conﬁrm
dementia diagnosis or absence of dementia by the time of
death for the sub-sample who had donated to the study’s
brain donation programme; (3) the cohort was ﬂagged for
mortality with the Ofﬁce of National Statistics so the study
resource includes cause of death data from death certiﬁcates.
Prevalent dementia at Survey 4 was deﬁned as dementia
diagnosed by latest CAMDEX assessment (all prior to Survey
4) and incident dementia was based on either post-mortem
consensus diagnosis or death certiﬁcate data, excluding prev-
alent CAMDEX dementia cases. More than half of Survey 4
participants had undergone at least one CAMDEX assessment
(231/446), of whom 94/231 were diagnosed with prevalent
dementia. More than a quarter of Survey 4 participants had
post-mortem consensus clinical diagnostic assessment
(121/446). Of these, 70/121 were diagnosed with dementia, of
whom the majority (51/70) had incident dementia, i.e. no
prior CAMDEX dementia diagnosis. Death certiﬁcate data
were available for all participants, for whom 66 death certiﬁ-
cates mentioned dementia. For 37 of these 66 there had been
neither a CAMDEX dementia diagnosis nor any post-mortem
clinical consensus diagnostic assessment. This totals 88 cases
of incident dementia after Survey 4.
As the CC75C data sources may not capture all prevalent
and incident dementia, we also included severe cognitive
impairment in our overall outcome. Individuals with MMSE
scores 0–17 were categorized as severely cognitively impaired
(Tombaugh & McIntyre, 1992). Eighty-ﬁve cases of prevalent
severe cognitive impairment could be identiﬁed based on
their MMSE score at Survey 4 and 52 individuals developed
incident severe cognitive impairment after Survey 4. Combin-
ing these two outcomes resulted in 140 prevalent and 84 inci-
dent cases of severe cognitive impairment or dementia
(see Figure 2).
Survey 10  
(Year 28) 
 n = 3 
Follow-up 
all cohort 
survivors 
[100% of 
attrition  
= death] 
Survey 1  
(Year 0)  
n = 2,610 of which  
n = 2,166 followed-up 
Baseline survey of 
dementia prevalence 
Survey 4 
(Year 10) 
 n = 446 
Follow-up 
all cohort 
survivors 
including 
CAMDEX  
[79% of 
attrition  
= death] 
Survey 2  
(Year 2)  
n = 1,117  
CAMDEX participants 
excluded by design for 
incidence survey 
[58% of attrition 
due to death] 
Survey 3
(Year 7)  
n = 713 
Follow-up of all cohort 
survivors including 
CAMDEX participants 
[77% of attrition  
due to death] 
Wave 1 CAMDEX  
n = 530 
Wave 2 CAMDEX  
n = 467 
Wave 3 CAMDEX  
n = 125 
Survey 8 
(Year 23) 
 n = 11 
Follow-up 
of donors 
only  
[100% of 
attrition  
= death] 
Survey 5 
(Year 13) 
 n = 233 
Follow-up 
all cohort 
survivors 
[86% of 
attrition  
= death] 
Survey 6 
(Year 17) 
 n = 110 
Follow-up 
all cohort 
survivors 
[97% of 
attrition  
= death] 
Survey 7  
(Year 21) 
 n = 44 
Follow-up 
all cohort 
survivors 
[99% of 
attrition  
= death] 
Survey 9  
(Year 23) 
 n = 7 
Follow-up 
all cohort 
survivors 
[100% of 
attrition  
= death] 
1985 2013
Figure 1. CC75C study design.
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Demographics
Age and sex were conﬁrmed from general practice lists when
originally enrolled in the study and educational level was self-
reported at baseline through questions on what age the partici-
pant left school and years of education after school leaving age.
Modiﬁable risk and protective factors
For the present study, data were available on 8 out of 12 mod-
iﬁable risk and protective factors identiﬁed in a recent review:
diabetes, depression, coronary heart disease, hypertension,
alcohol consumption, smoking status, physical activity and
cognitive activity (Deckers et al., 2015). Risk factors were
based on either self-reported or proxy-reported information
and were either dichotomized according to cut-offs as
described below or rated present or absent. Information from
proxy informants was used when participants’ cognitive abili-
ties interfered with accurate reporting. The presence of coro-
nary heart disease (angina pectoris or heart attack), diabetes
and hypertension were based on self- or proxy-report of a
doctor’s diagnosis. For smoking, participants were divided
into current smokers and non-smokers. Alcohol consumption
was based on the reported frequency of current alcohol use,
with 1–14 glasses per week considered low-to-moderate,
according to recent UK alcohol guidelines (Department of
Health, 2016). Individuals were considered depressed if they
scored 6 or higher on the 10-item CAMDEX Depressive Symp-
toms Scale (range 0–11) (Girling et al., 1995). The physical
activity measure categorized participants as active individuals
who engaged in one or more forms of physical activity or
exercise (e.g. walking, cycling, do-it-yourself, gardening, etc.)
during the last week and the inactive who did none of these.
For cognitive activity (intellectual engagement), participants
were categorized as active or inactive based on reported
activities undertaken in the last fortnight (e.g. visits to places
of interest, hobbies, reading) and having taken part in educa-
tion or training in recent years. Engagement in three or more
of these activities was considered as cognitively active.
LIBRA-index
The LIBRA score was developed after triangulation of results
from a systematic literature review on risk and protective fac-
tors for dementia and an expert consensus study (Deckers
et al., 2015), as part of the European (FP7) INnovative, Midlife
INtervention for Dementia Deterrence (In-MINDD) project
(O’Donnell et al., 2015). It consists of 12 modiﬁable risk and
protective factors that can be targeted by tailored lifestyle
interventions and primary prevention: physical inactivity,
smoking, (low-to-moderate) alcohol use, (high) cognitive
activity, healthy diet, depression, hypertension, obesity, diabe-
tes, hypercholesterolemia, coronary heart disease and renal
disease. A weight is assigned to each factor, based on the fac-
tor’s relative risk (Deckers et al., 2015). Weights are then stan-
dardized and summed to yield the ﬁnal LIBRA score (range
from ¡5.9 to C12.7), with higher scores indicating greater
risk. In contrast to other risk indices, LIBRA is based on modiﬁ-
able risk and protective factors only, and hence assesses an
individual’s potential for dementia prevention. A modiﬁed
version of the LIBRA score was developed for the purpose of
validation in older cohorts. It consists of 10 factors, excluding
the risk factors obesity and hypertension, since these are con-
sidered to be major risk factors in midlife only. In CC75C, sta-
tus information was available for 7 of the 10 factors from the
modiﬁed LIBRA score (range from ¡4.2 to C 7.0). No informa-
tion was available for diet, renal dysfunction and
hypercholesterolemia.
Statistical analysis
Independent samples t-tests and x2-tests were used to exam-
ine differences in risk factors and demographic variables
between participants with incident severe cognitive
impairment or dementia and non-affected individuals. Multi-
ple imputation was used to impute missing values for the
eight risk and protective factors, but only for participants with
less than three missing factors (others were listwise-deleted).
Multivariate imputation by chained equations was carried out
using all non-missing data on risk and protective factors and
socio-demographic covariates (age, sex and educational level)
(White, Royston, & Wood, 2011). Ten imputed datasets were
created and the results combined using Rubin’s rules (Rubin,
1996). Separate logistic regressions tested whether individual
risk and protective factors and the continuous LIBRA score
were associated with odds for severe cognitive impairment or
dementia in crude analyses (Model 1) or after adjustment for
age, sex and educational level (Model 2). All analyses were
done in Stata 13.1 (StataCorp, College Station, TX, USA), and
the level of statistical signiﬁcance used was p < 0.05 in
two-sided tests.
Results
Sample characteristics
After exclusion of 140 cases of prevalent severe cognitive
impairment or dementia and 10 individuals with missing
MMSE data after Survey 4, the total outcome-free sample at
Survey 4 consisted of 296 participants. The mean age was
87.9 (SD 3.2, 84–102) years, and 201 (68%) were female. Dur-
ing the 18-year follow-up, 84 individuals (28%) developed
severe cognitive impairment or dementia.
Figure 2. Survey 4 cases of incident severe cognitive impairment or dementia.
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Risk and protective factors
Status information for all eight risk and protective factors was
available in 226 participants (76%). As described above, data
were imputed for those participants with one (n D 38) or two
(n D 14) missing factors. From the total of 2368 values for the
8 factors, 66 values were imputed (2.8%). We excluded 18 par-
ticipants with more than two missing factors from the analy-
ses, of whom 9 (50%) individuals developed severe cognitive
impairment or dementia. This resulted in a total sample of
278 participants with a mean age of 87.8 (SD 3.1, 84–102)
years, of whom 189 (68%) were female. Of these, 75 individu-
als (27%) developed severe cognitive impairment or demen-
tia. The characteristics of this sample are illustrated in Table 1.
None of the risk or protective factors was signiﬁcantly associ-
ated with severe cognitive impairment or dementia in crude
analyses or after adjustment for age, sex and educational
level. Similar results were found in separate analyses for
dementia and severe cognitive impairment (see Table 2).
LIBRA-index
Seven of the eight risk factors from imputed datasets were
used to calculate individuals’ modiﬁed LIBRA scores (hyper-
tension omitted as explained above; range from ¡0.8 to 2.2).
Lower LIBRA scores were signiﬁcantly associated with
increased odds of severe cognitive impairment or dementia,
Table 1. Characteristics of Survey 4 participants (excluding prevalent cases and participants with data missing for more than two risk/protective factors) by outcome
status.
Incident dementia status
(n D 323)a
Incident severe cognitive
impairment status (n D 318)b
Incident dementia/severe cognitive
impairment status (n D 278)c
Variable
Yes,
n D 76
No,
n D 247
p-Value Yes,
n D 44
No,
n D 274
p-Value Yes,
n D 75
No,
n D 203
p-Value
Age, mean (SD) 87.7 (2.7) 88.1 (3.4) 0.362 87.8 (3.1) 87.7 (3.1) 0.987 87.6 (3.0) 87.9 (3.2) 0.573
Age at death, mean (SD) 94.2 (3.8) 93.0 (4.4) 0.025 96.7 (3.9) 92.5 (4.1) 0.000 95.1 (3.9) 92.5 (4.3) 0.000
Female, n (%) 60 (79.0) 170 (68.8) 0.088 37 (84.1) 179 (65.3) 0.013 59 (78.7) 130 (64.0) 0.020
Educational level, n (%) 0.478 0.346 0.694
Left school aged less than 15 years 43 (56.6) 151 (61.1) 29 (65.9) 160 (58.4) 42 (56.0) 119 (58.6)
Left school aged 15 years old or more 33 (43.4) 96 (38.9) 15 (34.1) 114 (41.6) 33 (44.0) 84 (41.4)
Marital status, n (%) 0.342 0.344 0.326
Married 15 (19.7) 51 (20.7) 7 (15.9) 60 (21.9) 15 (20.0) 46 (22.7)
Widowed 52 (68.4) 165 (66.8) 31 (70.5) 182 (66.4) 53 (70.7) 131 (64.5)
Separated/divorced – 9 (3.6) – 9 (3.3) – 8 (3.9)
Never married 9 (11.8) 22 (8.9) 6 (13.6) 23 (8.4) 7 (9.3) 18 (8.9)
Place of residence, n (%) 0.828 0.297 0.567
House/ﬂat/granny ﬂat 60 (79.0) 192 (77.7) 34 (77.3) 215 (78.5) 60 (80.0) 162 (79.8)
Warden controlled 8 (10.5) 23 (9.3) 7 (15.9) 26 (9.5) 9 (12.0) 18 (8.9)
Long-term care institute 8 (10.5) 32 (13.0) 3 (6.8) 33 (12.0) 6 (8.0) 23 (11.3)
Social class, n (%) 0.980 0.810 0.905
Non-manual skills 35 (47.3) 115 (47.1) 21 (48.8) 127 (46.9) 36 (49.3) 97 (48.5)
Manual skills 39 (52.7) 129 (52.9) 22 (51.2) 144 (53.1) 37 (50.7) 103 (51.5)
Disabilities in ADLs or IADLs, n (%) 0.032 0.054 0.004
No disability 35 (46.7) 80 (32.4) 23 (52.3) 92 (33.7) 38 (51.4) 65 (32.0)
Disability in IADLs only 21 (28.0) 67 (27.1) 10 (22.7) 76 (27.8) 20 (27.0) 56 (27.6)
Disability in both ADLs and IADLs 19 (25.3) 100 (40.5) 11 (25.0) 105 (38.5) 16 (21.6) 82 (40.4)
MMSE score at Survey 4, mean (SD)d 21.72 (6.7) 24.05 (5.4) 0.002 23.4 (3.5) 25.3 (3.2) 0.001 24.3 (3.5) 25.6 (3.1) 0.003
Number of available risk/protective factors,
n (%)e
0.582 0.256 0.222
<7 risk/protective factors 3 (4.0) 16 (6.5) – 16 (5.8) 1 (1.3) 13 (6.4)
7 risk/protective factors 13 (17.1) 34 (13.8) 7 (15.9) 39 (14.2) 10 (13.3) 28 (13.8)
8 risk/protective factors 60 (79.0) 197 (79.8) 37 (84.1) 219 (79.9) 64 (85.3) 162 (79.8)
Diabetes, n (%)e 3/76 (4.0) 12/246 (4.9) 0.736 2/44 (4.6) 13/273 (4.8) 0.950 2/75 (2.7) 11/202 (5.5) 0.331
Heart disease, n (%)e 12/75
(16.0)
59/245
(24.1)
0.141 7/44 (15.9) 68/272 (25.0) 0.189 12/74
(16.2)
51/202
(25.3)
0.113
Hypertension, n (%)e 13/75
(17.3)
54/244
(22.1)
0.372 9/44 (20.5) 64/272 (23.5) 0.653 14/75
(18.7)
46/201
(22.9)
0.450
Depression, n (%)e 8/74 (10.8) 31/235
(13.2)
0.591 5/44 (11.4) 31/261 (11.9) 0.922 7/74 (9.5) 24/194
(12.4)
0.505
Smoking, n (%)e 5/73 (6.9) 14/246 (5.7) 0.713 2/44 (4.6) 17/271 (6.3) 0.655 4/74 (5.4) 12/202 (5.9) 0.866
Low-to-moderate alcohol use, n (%)e 22/68 (32.4) 70/225 (31.1) 0.847 17/39 (43.6) 78/250 (31.2) 0.126 23/68 (33.8) 60/185 (32.4) 0.835
High cognitive activity, n (%)e 35/74
(47.3)
95/236
(40.3)
0.284 23/42
(54.8)
111/264
(42.1)
0.123 40/74
(54.1)
82/194
(42.3)
0.083
Physical inactivity, n (%)e 21/74 (28.4) 79/233 (33.9) 0.377 9/44 (20.5) 85/258 (33.0) 0.098 17/74 (23.0) 61/190 (32.1) 0.144
LIBRA score, mean (SD)f,g ¡0.93 (2.2) ¡0.51 (2.2) 0.154 ¡1.31 (2.4) ¡0.60 (2.2) 0.050 ¡1.29 (2.2) ¡0.60 (2.2) 0.022
Note: Figures may not sum to 100% because of rounding.
Abbreviations: ADL – activities of daily living; IADL – instrumental activities of daily living; LIBRA – LIfestyle for BRAin health; MMSE – Mini-Mental State Exami-
nation; SD – standard deviation.
aMissing data: social class n D 5; disabilities in ADLs or IADLs n D 1; MMSE score at Survey 4 n D 10; diabetes n D 1; heart disease n D 3; hypertension n D 4;
depression n D 14; smoking n D 4; low-to-moderate alcohol use n D 30; high cognitive activity n D 13; physical inactivity n D 16
bMissing data: social class n D 4; disabilities in ADLs or IADLs n D 1; MMSE score at Survey 4 n D 12; diabetes n D 1; heart disease n D 2; hypertension n D 2;
depression n D 13; smoking n D 3; low-to-moderate alcohol use n D 29; high cognitive activity n D 12; physical inactivity n D 16
cMissing data: social class n D 5; disabilities in ADLs or IADLs n D 1; MMSE score at Survey 4 n D 8; diabetes n D 1; heart disease n D 2; hypertension n D 2;
depression n D 10; smoking n D 2; low-to-moderate alcohol use n D 25; high cognitive activity n D 10; physical inactivity n D 14.
dMMSE score range: 0–30.
eBefore data imputation.
fAfter data imputation.
gModiﬁed (7-item) LIBRA score range: ¡4.2 to C7.0.
Values in bold are statistically signiﬁcant (p < 0.05).
4 K. DECKERS ET AL.
but this association was no longer signiﬁcant when age, sex
and educational level were added as covariates (see Table 2).
Separate analyses for dementia showed no signiﬁcant results,
but lower LIBRA scores were signiﬁcantly associated with
higher odds of severe cognitive impairment even after adjust-
ment for socio-demographic covariates.
Sensitivity analyses
We performed two sensitivity analyses. First, to further investi-
gate the direction of effects, the same analysis procedure for
incident dementia as outcome was repeated with participants
in Survey 3 (year 7; n D 560 after exclusion of 153 cases of
prevalent dementia), a larger sample with longer follow-up
but with information available on only six risk factors: diabe-
tes, heart disease, hypertension, depression, high cognitive
activity and physical inactivity. Again, data were imputed for
those participants with one (n D 78) or two (n D 29) missing
factors (imputation of 4.2%). As a result, the sample for these
sensitivity analyses totalled 546 participants (mean age D
85.5 (SD 3.6, 81–103) years; 69% females; 17% developed
dementia). Individuals with dementia were on average youn-
ger and more often female, and they died at a younger age in
comparison with participants without dementia. Physical inac-
tivity showed a protective effect and high cognitive activity
was associated with an increased risk of incident dementia,
but these effects were no longer signiﬁcant or of only border-
line signiﬁcance when adjusted for age, sex and educational
level (data not shown). Second, we studied whether results
were due to inclusion of participants with mild or moderate
cognitive impairment at Survey 4. For this, we restricted the
sample to those with an MMSE score >21 and those with an
MMSE score>25. Results were similar to the full sample analy-
ses (data not shown).
Discussion
Our study shows that modiﬁable risk and protective factors
did not predict odds of severe cognitive impairment or
dementia in the very old, even after adjustment for age, sex
and educational level. Similar results were found when severe
cognitive impairment and dementia were taken as separate
outcomes, when using a larger sample and longer follow-up
period (up to 21 years; Survey 3; incident dementia as out-
come) and when using stricter cut-offs for prevalent cognitive
impairment (MMSE score >21 or >25), though results for
physical inactivity and high cognitive activity were less clear
and in an unexpected direction. Additionally, higher LIBRA
scores did not increase the odds for dementia. It seems that
the predictive value of modiﬁable risk and protective factors
for dementia in the very old is poor. Therefore, dementia risk
prediction models focusing on very old populations (i.e. 85C
years) developed to date have included other factors such as
age, cognitive test performance, brain imaging measures or
apolipoprotein E genotype (Barnes et al., 2009; Pekkala et al.,
2017; Tang et al., 2015). It is important to note that inclusion
of these non-modiﬁable factors will only increase the predic-
tive accuracy of the risk prediction model, but will not provide
information regarding an individual’s potential for dementia
prevention.
These ﬁndings suggest that targeting common modiﬁable
risk factors in the very old might not have a serious impact on
future dementia risk, and hence a different approach might
be more appropriate. Indeed, previous randomized trials
focusing on non-midlife populations generally produced neg-
ative ﬁndings (Peters et al., 2008; van Charante et al., 2016).
The HYVET-COG trial showed that antihypertensive treatment
did not reduce the incidence of dementia in participants
aged 80 years or older (Peters et al., 2008). The multidomain
pre-DIVA trial focusing on vascular care in persons aged
Table 2. Prediction of outcome by risk factors and LIBRA score.
Incident dementia
(n D 323; 76 cases)
Incident severe cognitive impairment
(n D 318; 44 cases)
Incident dementia/severe cognitive impairment
(n D 278; 75 cases)
Model 1a
Variable OR 95% CI p-Value OR 95% CI p-Value OR 95% CI p-Value
Diabetes 0.76 0.21–2.75 0.674 0.93 0.20–4.29 0.930 0.46 0.10–2.11 0.315
Heart disease 0.61 0.31–1.21 0.154 0.57 0.24–1.34 0.196 0.58 0.29–1.16 0.120
Hypertension 0.74 0.38–1.45 0.380 0.84 0.38–1.84 0.664 0.77 0.40–1.51 0.448
Depression 0.78 0.34–1.78 0.549 0.96 0.35–2.61 0.931 0.77 0.31–1.88 0.566
Smoking 1.28 0.45–3.64 0.639 0.70 0.16–3.14 0.639 0.92 0.29–2.95 0.886
Low-to-moderate alcohol use 1.04 0.57–1.88 0.908 1.64 0.84–3.21 0.146 1.04 0.57–1.91 0.888
High cognitive activity 1.36 0.81–2.29 0.248 1.68 0.87–3.24 0.121 1.59 0.93–2.73 0.091
Physical inactivity 0.79 0.44–1.40 0.413 0.53 0.24–1.15 0.110 0.63 0.34–1.17 0.145
LIBRA scorec 0.92 0.82–1.03 0.153 0.85 0.73–0.99 0.036 0.87 0.77–0.99 0.031
Model 2b
OR 95% CI p-Value OR 95% CI p-Value OR 95% CI p-Value
Diabetes 0.71 0.19–2.62 0.607 0.94 0.20–4.48 0.939 0.44 0.09–2.08 0.301
Heart disease 0.67 0.33–1.34 0.257 0.61 0.26–1.46 0.269 0.64 0.32–1.31 0.223
Hypertension 0.69 0.35–1.37 0.285 0.76 0.34–1.70 0.504 0.72 0.36–1.43 0.354
Depression 0.75 0.33–1.74 0.508 0.95 0.34–2.65 0.927 0.73 0.30–1.81 0.497
Smoking 1.51 0.52–4.42 0.453 1.04 0.22–4.90 0.962 1.22 0.36–4.09 0.749
Low-to-moderate alcohol use 1.13 0.61–2.08 0.692 1.98 0.99–3.97 0.054 1.19 0.63–2.25 0.588
High cognitive activity 1.26 0.74–2.14 0.395 1.65 0.84–3.21 0.145 1.48 0.85–2.57 0.163
Physical inactivity 0.78 0.44–1.41 0.417 0.50 0.23–1.10 0.084 0.62 0.33–1.15 0.130
LIBRA scorec 0.93 0.83–1.05 0.228 0.85 0.73–0.99 0.040 0.88 0.78–1.00 0.053
Note: Abbreviations: OR – odds ratio; CI – conﬁdence interval; LIBRA – LIfestyle for BRAin health.
aModel 1: crude model.
bModel 2: adjusted for age, sex and educational level.
cThe modiﬁed version of the LIBRA score consists of the following factors: diabetes, heart disease, depression, smoking, low-to-moderate alcohol use, high cog-
nitive activity and physical inactivity.
Values in bold are statistically signiﬁcant (p < 0.05).
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70–78 years showed non-signiﬁcant results, although demen-
tia risk could be reduced by antihypertensive treatment in
those not previously treated (van Charante et al., 2016). There-
fore, the Lancet Neurology Commission recently advised that
dementia prevention studies should start in midlife (Winblad
et al., 2016).
It is possible that other risk or protective factors may play a
role in the aetiology of dementia in the very old. This group
of older people has probably survived several morbidities ear-
lier in life and managed to live with chronic conditions like
diabetes or coronary heart disease until advanced age. They
may possess longevity genes or other resilience factors, which
protect them from getting dementia at a higher rate than
those unexposed to such risk factors. On the other hand, it is
also possible that dementia is an irreversible process in very
old adults. In other words, the CC75C study participants who
developed incident dementia may have had fairly advanced
underlying pathology at baseline already (neurodegenerative,
vascular or mixed) but of a slowly progressive nature that had
not been diagnosed at an earlier stage. We hypothesize that
this degenerative process cannot be reversed by lifestyle
adaptations. It is also notable that the direction of most of the
effect estimates was counter-intuitive (even in the sensitivity
analysis). Inverse associations were found for diabetes, heart
disease, hypertension, depression, low-to-moderate alcohol
use, high cognitive activity, physical inactivity and the LIBRA
score. Based on the above, it could be hypothesized that indi-
viduals at high (polygenetic) risk for dementia but with a
healthy lifestyle survive longer and therefore have higher
odds of developing dementia in late life in comparison with
the rest of the survivors. Taken together, these results indicate
that more studies are needed that investigate the effects of
modiﬁable risk and protective factors on dementia risk in the
very old, including studies aimed at detection of novel candi-
date risk factors.
The strengths of our study include the prospective study
design focused on a representative population of the very
old, the long follow-up period (up to 18 years), and the use of
interviews with proxy informants to minimize lost to follow-
up that could under-represent the frailest elderly and to
replace missing data. However, our study has several limita-
tions. First, the sample size was relatively small and, although
sizeable for research with this very old age group, has limited
power to detect signiﬁcant associations. Therefore, a sensitiv-
ity analysis with a larger sample and longer follow-up period
was conducted to further investigate the direction of effects.
Second, some selection bias may have occurred since indi-
viduals who were too ill or refused to participate due to medi-
cal reasons were more likely to drop out of the study. Third,
the ascertainment of exposures was based on self-reported or
proxy-reported information which could have led to response
bias and non-differential exposure misclassiﬁcation. Given the
old age and physical condition of the study participants and
the absence of sufﬁcient resources to conduct neuropsycho-
logical and neurological examinations, full examinations of
medical records, laboratory test and brain scans at each sur-
vey and for each participant, the structured survey interview
was the best option. Fourth, the diagnosis of dementia was
partly based on death certiﬁcate records. A drawback of such
data is the lack of information on how any dementia reported
was diagnosed. Moreover, absence of death certiﬁcate
recorded dementia cannot be taken as conﬁrmation that
dementia was absent, with the possibility of non-differential
outcome misclassiﬁcation (e.g. under-reporting). The discrep-
ancy between the prevalence of incident dementia and inci-
dent severe cognitive impairment in Survey 4 may reﬂect
inadequate identiﬁcation of dementia after death and may
also reﬂect non-random missing cognitive data. Participants
whose cognitive abilities declined rapidly may not have been
interviewed after this downfall, either having died or having
only proxy interviews by the next survey, and are therefore
missing from the severe cognitive impairment category. Fifth,
death before follow-up and non-response are likely to be
associated with both the outcomes and factors investigated.
Additionally, participants with more than two missing factors
were excluded from the analyses. Higher proportion of this
sub-sample (n D 18) than of the included participants lived in
a long-term care institute, were disabled, had dementia and
had missing MMSE data. These issues are likely to inﬂuence
the investigated associations.
In sum, our results indicate that in the very old the associa-
tions between well-known risk and protective factors and
subsequent development of dementia are not well estab-
lished, but further research is required. It supports the idea
that the effects of these factors are more pronounced at other
life stages such as midlife. Future campaigns should focus
their preventive message on these younger age groups in
anticipation of long-term health beneﬁt.
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